BBOT begins trading on Nasdaq after $382M SPAC merger completion
Tweet Send to a Friend
BridgeBio Oncology Therapeutics completed its business combination with Helix Acquisition Corp. II on August 11, 2025, and commenced trading on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
